We could not find any results for:
Make sure your spelling is correct or try broadening your search.
The current MRUS market cap is 3.03B. The company's latest EPS is USD and P/E is N/A.
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 13.5M | 10.48M | 11.03M | 8.94M | 7.89M |
Operating Income | -36.75M | -33.89M | -38.37M | -98.52M | -46.81M |
Net Income | -39.74M | -32.03M | -23.01M | -60.15M | -34.46M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Revenue | 31.13M | 29.94M | 49.11M | 41.59M | 43.95M |
Operating Income | -58.66M | -75.88M | -89.98M | -160.04M | -156.55M |
Net Income | -55.15M | -85.51M | -66.82M | -131.19M | -154.94M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 338.52M | 363.62M | 492.19M | 455.49M | 498.08M |
Total Liabilities | 121M | 106.22M | 98.8M | 99.15M | 148.64M |
Total Equity | 217.52M | 257.41M | 393.39M | 356.34M | 349.45M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Total Assets | 263.38M | 231.22M | 456.6M | 376.54M | 455.49M |
Total Liabilities | 132.08M | 128.95M | 140.4M | 129.49M | 99.15M |
Total Equity | 131.3M | 102.26M | 316.2M | 247.06M | 356.34M |
Quarter End | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -36.74M | -78.33M | -105.86M | -142.21M | -44.39M |
Investing | -8.41M | -32.93M | -24.9M | -27.02M | -12.08M |
Financing | 217k | 66.18M | 228.59M | 230.09M | 30.16M |
Year End 31 December 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
---|---|---|---|---|---|
USD (US$) | USD (US$) | USD (US$) | USD (US$) | USD (US$) | |
Operating | -63.05M | -79.9M | -59.63M | -149.9M | -142.21M |
Investing | 24.17M | -1.49M | -146.62M | 2.8M | -27.02M |
Financing | 74.23M | 39.52M | 281.96M | 58.74M | 230.09M |
Market Cap | 3.03B |
Price to Earnings Ratio | N/A |
Price to Sales Ratio | 0 |
Price to Cash Ratio | 0 |
Price to Book Ratio | 0 |
Dividend Yield | - |
Shares Outstanding | 57.88M |
Average Volume (1 week) | 2M |
Average Volume (1 Month) | 1.55M |
52 Week Change | 138.83% |
52 Week High | 61.61 |
52 Week Low | 19.805 |
Spread (Intraday) | 0.48 (0.9%) |
Company Name | Merus NV |
Address |
uppsalalaan 17 utrecht, utrecht 3584 CT |
Website | https://www.merus.nl |
Industry | gen med & surgical hospitals (8062) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions